MBX Biosciences, Inc. Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2023 Dec2024
Operating Activities
Depreciation and Depletion 0.20M0.24M
Share-based Compensation 2.04M5.22M
Gains from Investment Securities 0.46M1.22M
Cash from Operations -31.98M-54.68M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 1.04M2.93M
Depreciation & Amortization (CF) 0.20M0.24M
Change in Working Capital
Change in Account Payables 0.41M3.93M
Change in Accured Expenses 0.04M3.17M
Other Working Capital Changes 1.05M2.35M
Investing Activities
Capital Expenditures 0.13M0.87M
Change in Acquisitions & Divestments 33.00M79.75M
Cash from Investing Activities -30.93M-160.59M
Financing Activities
Other financing activities 4.06M
Cash from Financing Activities 69.22M234.10M
Additional items
Change in Cash 6.31M18.83M
Free Cash Flow -32.11M-55.55M
Net Cash Flow 6.31M18.83M